{
    "code": "12000337",
    "許可證字號": "內衛藥製字第000337號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/05\/25",
    "發證日期": "58\/04\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY01200033702",
    "中文品名": "新斯狄格明注射液",
    "英文品名": "NEOSTIGMINE INJECTION \"CHI SHENG\"",
    "適應症": "各種腸管麻痺及排尿困難。由於肌無力、肌肉麻痺、腦溢血、小兒麻痺、神經痛、關節痛等引起之各種運動障礙。眼肌無力症、綠內障、瞳孔反應檢查等",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "NEOSTIGMINE METHYLSULFATE",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1802006200  濟生化學製藥廠股份有限公司",
    "申請商地址": "新竹縣湖口鄉新竹工業區實踐路３號",
    "主製造廠": {
        "製造廠名稱": "1802006300  濟生化學製藥廠股份有限公司",
        "製造廠廠址": "新竹縣湖口鄉新竹工業區實踐路３號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204000920",
            "成分名稱": "NEOSTIGMINE METHYLSULFATE",
            "含量描述": "0.5",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 12000337-2014-02-12.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=12000337&Seq=001&Type=9"
        }
    ]
}